Navigation Links
Petition to Ban Power Morcellator Surgery Now Has 62,800 Supporters, Bernstein Liebhard LLP Reports
Date:8/15/2014

New York, NY (PRWEB) August 15, 2014

More than 62,800 signatures are now included on a petition created by a Boston couple campaigning to end power morcellator (http://www.gynecaremorcellatorlawsuit.com/ ) surgery in the U.S., Bernstein Liebhard LLP reports.

As of August 15th, the Change.org petition had 62,927 supporters who similarly seek to ban use of the devices in laparoscopic hysterectomy and fibroid removal procedures. The campaign was spearheaded by the husband of a woman who was diagnosed with uterine leiomyosarcoma, a life-threatening form of uterine cancer, after having fibroids removed in October 2013. Since then, concerns surrounding the possible risk for uterine morcellation procedures to promote the spread of uterine cancer cells throughout the peritoneal cavity have continued to gain momentum in the U.S.

“We are pleased that more signatures have been added to this petition, as our Firm continues to hear from women whose uterine sarcoma and other cancers allegedly spread after power morcellator surgeries,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is actively investigating power morcellator lawsuits on behalf of women who may have received life-threatening cancer diagnoses after undergoing a uterine morcellation procedure.

Morcellator Lawsuits

The possible risks surrounding uterine morcellation have continued to gain media attention over the past several months, especially after the U.S. Food and Drug Administration (FDA) issued a public health alert in April that warned of the association between power morcellators and the spread of uterine sarcoma and other cancers. Among other things, the FDA alert estimated that 1 in every 350 women having fibroids removed may have undetected uterine sarcoma or another cancer prior to surgery, which may not be discovered until after fibroids are removed and biopsied.

Most recently, a study published in the Journal of the American Medical Association found that 1 in 368 women undergoing power morcellator surgeries may have undiagnosed uterine cancers. The research, which was released on July 22nd, 2014, also showed a higher likelihood of undetected cancer in women older than 65, and found that 32 percent of morcellation patients with the undiagnosed disease were younger than 50.*

On July 30th, Johnson & Johnson announced that it would be removing all power morcellators marketed by its subsidiary, Ethicon, Inc. from the market following its previous decision to cease sales of the devices. A notice posted on the company’s website indicated that its Gynecare Morcellex, Gynecare X-Tract and Morcellex Sigma morcellator systems would be withdrawn due to uncertain risks associated with their use.**

Women who may have been diagnosed with uterine cancer after power morcellator surgery may be eligible to file a lawsuit seeking compensation for damages allegedly caused by the device. To learn more about the possible risk between uterine morcellation and uterine sarcoma, please visit Bernstein Liebhard LLP’s website. To obtain a free legal review, please call 800-511-5092.

*jama.jamanetwork.com/article.aspx?articleid=1890400, JAMA, July 22, 2014
**ethicon.com/sites/default/files/managed-documents/Ethicon%20Morcellation%20Devices%20Customer%20Letter%20Final.pdf, Ethicon, Inc., July 30, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.gynecaremorcellatorlawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma/prweb12099253.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Casey Group's Sales Navigator Wins 2012 Best Mobility App in the New Jersey Technology Council's Mobile Application Competition
2. Clemson bioengineering team wins undergraduate design competition
3. New insights on cell competition
4. Managing care and competition
5. Kershaw, Cutter & Ratinoff Petitions FDA To Take Aggressive Action To Help People With Hip Replacement Problems
6. Amerejuve Dominates Houston's MedSpa Competition With Rapid Expansion: Houston's #1 MedSpa Opens Eighth Location in Kingwood
7. Aventura Rejuvenation Announces Their Biggest Loser 30 Day Weight Loss Competition
8. Knobbly knees in competition with fingerprints
9. The Human Brain Project: Winner of the of the largest European scientific funding competition
10. $5 million awarded in Sixth Starr Cancer Consortium Grant Competition
11. Mass. Eye and Ear researcher among winners of competition for Audacious ideas in research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... Francisco Canales, MD and Heather Furnas, ... Valley office. The technique utilizes the body’s own healing abilities to quickly rejuvenate ... are part of only a select few cosmetic surgeons bringing this procedure to ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active ... Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division ... completed his first three-year term as chief and began a second three-year term in ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... PROSHRED franchises from across the country gathered at the La Valencia Hotel in ... performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking away ...
(Date:2/5/2016)... ... 05, 2016 , ... Give To Cure today announced that it ... to Give To Cure’s campaign that is crowdfunding clinical trials to help find cures ... payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at Source Capital Group,s 2016 ... NY at 2:15 p.m. ET on Wednesday, February ... Panel discussion taking place at 3:15 p.m. ET. ... one hour after the conclusion of the live event. The ...
(Date:2/5/2016)... , February 5, 2016 ... Market Research report states that the global active pharmaceuticals ... and is predicted to reach US$185.9 bn by 2020. ... 6.50% from 2014 to 2020. The title of the ... Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology: